EX-99.1(B)3 6 dex991b3.htm CONSOLIDATED STATEMENTS OF INCOME-NORMALIZED Prepared by R.R. Donnelley Financial -- Consolidated Statements of Income-Normalized
 
Exhibit 99.1 (b) 3
Normalized
CONSOLIDATED STATEMENTS OF INCOME
NDCHealth Corporation and Subsidiaries
 
(In thousands, except per share data)

    
Three Months Ended

 
    
May 31, 2002

    
May 31, 2001

 
Revenues:
                 
Information management
  
$
40,173
 
  
$
37,190
 
Network services and systems
  
 
54,331
 
  
 
46,927
 
    


  


    
 
94,504
 
  
 
84,117
 
    


  


Operating expenses:
                 
Cost of service
  
 
47,588
 
  
 
41,504
 
Sales, general and administrative
  
 
19,369
 
  
 
18,663
 
Depreciation and amortization
  
 
5,948
 
  
 
8,420
 
    


  


    
 
72,905
 
  
 
68,587
 
    


  


Operating income
  
 
21,599
 
  
 
15,530
 
    


  


Other income (expense):
                 
Interest and other income
  
 
639
 
  
 
624
 
Interest and other expense
  
 
(2,537
)
  
 
(2,348
)
Minority interest in losses
  
 
183
 
  
 
413
 
    


  


    
 
(1,715
)
  
 
(1,311
)
    


  


Income before income taxes and equity in losses of affiliated companies
                 
Information management
  
 
7,753
 
  
 
5,045
 
Network services and systems
  
 
12,131
 
  
 
9,174
 
    


  


    
 
19,884
 
  
 
14,219
 
    


  


Provision for income taxes
  
 
7,157
 
  
 
5,474
 
    


  


Income before equity in losses of affiliated companies
  
 
12,727
 
  
 
8,745
 
Equity in losses of affiliated companies, net of income taxes
  
 
(314
)
  
 
(299
)
    


  


Net income
  
$
12,413
 
  
$
8,446
 
    


  


Basic earnings per share:
  
$
0.36
 
  
$
0.25
 
    


  


Shares
  
 
34,260
 
  
 
33,970
 
Diluted earnings per share:
  
$
0.35
 
  
$
0.24
 
    


  


Shares
  
 
39,331
 
  
 
35,368
 
 
Normalized results for the three months ended May 31, 2001 exclude revenues and operating expenses related to divested businesses of $4.3 million and $4.5 million respectively, and valuation adjustment in Medscape investment of $7.0 million.